-
September 20, 2019 Shedding light on new mechanisms related to cell migration
IRIC Investigators have made major discoveries involving the mechanisms regulating collective cell migration. Notably, this type of displacement is used by cancer cells that break away from a primary tumor to colonize another part of the body and form metastases…
![]()
-
September 13, 2019 Speeding up the drug discovery process to help patients: Michel Bouvier co-senior author of a study published in Nature Communications
An international research team has developed a new strategy that can predict the potential clinical implications of new therapeutic compounds based on simple cellular responses. This discovery was partly led by scientists affiliated with Université de Montréal (UdeM), and represents a major step forward in developing more effective drugs with fewer side effects, much faster than before. The researchers conducted their work at Centre de Recherche de l’Hôpital Ste-Justine and published their findings in the prestigious journal Nature Communications.
![]()
-
July 8, 2019 Treatment of leukemia: IRIC Investigators publish in Cancer Cell
Researchers at UdeM have discovered a molecular process implicated in the action of anti-leukemia drugs, opening new avenues for the development of effective treatments for this disease.
![]()
-
June 27, 2019 Trang Hoang is awarded the Ordre national du Québec and the Ordre de Montréal
On June 20, 2019, Trang Hoang, Principal Investigator at IRIC, was appointed Officer of the Ordre national du Québec. The honorary decoration, awarded by Premier François Legault, is the greatest distinction handed out by the Government of Quebec, paying tribute to exceptional people who have done outstanding work for the province.
![]()
-
September 6, 2019 Mrs. Élaine and Mr. Réal Raymond once again show their commitment by donating $100,000 in support of Brian Wilhelm’s research
IRIC is proud to announce a $100,000 donation from Mrs. Élaine and Mr. Réal Raymond in support of Brian Wilhelm’s research in pediatric leukemia.
The couple renews its philanthropic commitment… -
September 6, 2019 IRIC on the road: 2019 student recruitment tour
The Academic Affairs team will once again take part this fall in the IRIC on the road student recruitment tour by participating in many graduate studies fairs held by various Canadian universities.
These recruitment activities provide students with a valuable opportunity to meet… -
July 8, 2019 $110,250 raised at the 10th Blais Family Fund Golf Tournament to benefit IRIC
On Friday, July 5, 2019, 225 people gathered at the Buckingham Golf Club for the 10th Blais Family Fund Golf Tournament. A record amount of $110,250 was raised to support cancer research efforts carried out at IRIC. Pierre Blais, he himself a leukemia survivor, thanks to an experimental treatment suggested by Dr. Guy Sauvageau, Principal Investigator at IRIC, is the driving force behind the event, which every year brings together family and friends devoted to the cause.
-
July 1, 2019 IRIC Student Recruitment Event 2019
The IRIC Student Recruitment Event offers students interested in pursuing graduate studies in the field of cancer research a unique opportunity to participate in an international student recruitment event at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal. The 2019 edition took place from June 12th to 14th, 2019.
-
June 28, 2019 $150,000 in funding from the Richard and Edith Strauss Foundation for two promising cancer research projects
IRIC is proud to announce $150,000 in funding from the Richard and Edith Strauss Foundation for two promising cancer research projects. For the “Identification of biological targets influencing the response to anti-AML drugs” project, Dr. Guy Sauvageau received $100,000 in funding. As for Dr. Sonia Cellot, Paediatric hematologist at CHU Sainte-Justine, and Brian Wilhelm, they received $50,000 in financial support for their project titled “Characterising the stem/progenitor cell of origin of high fatality pediatric leukemia”.
-
June 6, 2019 $10M awarded to IRIC for the development of new cancer-fighting drugs and immunotherapies
IRIC has been awarded a 10-million dollar grant from the government of Quebec’s Fonds d’accélération des collaborations en santé (FACS), to develop new cancer-fighting drugs in collaboration with biopharmaceutical company Bristol-Myers Squibb and collaborators from seven academic research centres from Quebec and abroad.
-
May 10, 2019 Sébastien Lemieux
Sequencing of the 20,000 human genes produced countless data that must now be deciphered in order to give it meaning. Bioinformatician Sébastien Lemieux, of the Institute for Research in Immunology and Cancer of the Université de Montréal, devotes himself to that task in the field of cancer research.
-
May 8, 2019 First edition of Effervescence: a tremendous success!
The first edition of EFFERVESCENCE was held on April 24 and 25. Driven by Montréal InVivo and organized by a group of 14 partners from the milieu, this major event in the Life Sciences and Health Technologies sector brought together more than 550 people at TOHU.